{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:01Z","timestamp":1791356281399,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.pathol.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T20:00:38Z","timestamp":1493064038000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Non- BRCA familial breast cancer: review of reported pathology and molecular findings"],"prefix":"10.1016","volume":"49","author":[{"given":"Michael G.","family":"Keeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Visscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-3490","authenticated-orcid":false,"given":"Noralane M.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1147>3.0.CO;2-C","article-title":"Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families","volume":"92","author":"Dong","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/oxfordjournals.aje.a009833","article-title":"Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women","volume":"149","author":"Poole","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pathol.2017.03.002_bib3","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/cncr.20989","article-title":"A\u00a0cohort study of cancer risk in relation to family histories of cancer in the Utah population database","volume":"103","author":"Kerber","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1634\/theoncologist.2007-0242","article-title":"Familial risks for cancer as the basis for evidence-based clinical referral and counseling","volume":"13","author":"Hemminki","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.pathol.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/jama.1993.03510130069033","article-title":"A\u00a0comprehensive evaluation of family history and breast cancer risk. The Utah Population Database","volume":"270","author":"Slattery","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/djr114","article-title":"Confirmation of family cancer history reported in a population-based survey","volume":"103","author":"Mai","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.gim.0000237867.34011.12","article-title":"Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention","volume":"8","author":"Ramsey","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.pathol.2017.03.002_bib8","first-page":"134","article-title":"Population-based estimates of the prevalence of family history of cancer among women","volume":"4","author":"Hall","year":"2001","journal-title":"Community Genet"},{"key":"10.1016\/j.pathol.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A\u00a0strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pathol.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pathol.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer","volume":"17","author":"Maxwell","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.pathol.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13402-011-0010-3","article-title":"Pathology of hereditary breast cancer","volume":"34","author":"van der Groep","year":"2011","journal-title":"Cell Oncol"},{"key":"10.1016\/j.pathol.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pathol.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0046-8177(98)90389-6","article-title":"Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer","volume":"29","author":"Schrager","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0625.1998.tb00338.x","article-title":"Similarities of cutaneous and breast pathology in Cowden's Syndrome","volume":"7","author":"Schrager","year":"1998","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.pathol.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-X","article-title":"Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys","volume":"65","author":"Peto","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejso.2015.01.021","article-title":"Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer","volume":"41","author":"Aloraifi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.pathol.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2008.43","article-title":"Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases","volume":"21","author":"Colombo","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/modpathol.2010.37","article-title":"Pathology of hereditary breast cancer","volume":"23","author":"Da Silva","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/bcr3463","article-title":"PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer","volume":"15","author":"Deb","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.pathol.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10549-011-1357-x","article-title":"A\u00a0non-BRCA1\/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients","volume":"130","author":"Didraga","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pathol.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.25603","article-title":"Transcriptional characteristics of familial non-BRCA1\/BRCA2 breast tumors","volume":"128","author":"Fernandez-Ramires","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajhg.2010.02.008","article-title":"DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status","volume":"86","author":"Flanagan","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pathol.2017.03.002_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ijc.20723","article-title":"Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization","volume":"114","author":"Gronwald","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib29","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.0533805100","article-title":"Molecular classification of familial non-BRCA1\/BRCA2 breast cancer","volume":"100","author":"Hedenfalk","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2017.03.002_bib30","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.3800969","article-title":"Immunohistochemical classification of non-BRCA1\/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families","volume":"20","author":"Honrado","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.03.002_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.cej.0000203615.77183.97","article-title":"Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1\/2 families","volume":"15","author":"Jernstrom","year":"2006","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.pathol.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/00313020802035899","article-title":"Histopathological features of \u2018BRCAX\u2019 familial breast cancers in the kConFab resource","volume":"40","author":"Loughrey","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1038\/sj.onc.1210975","article-title":"Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes","volume":"27","author":"Melchor","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2017.03.002_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:BREA.0000003836.91844.b5","article-title":"p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations","volume":"82","author":"Sensi","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pathol.2017.03.002_bib35","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2017.03.002_bib36","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.ejca.2006.05.027","article-title":"Numerous high-risk epithelial lesions in familial breast cancer","volume":"42","author":"Hoogerbrugge","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","article-title":"BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study","volume":"16","author":"Musolino","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.pathol.2017.03.002_bib38","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-014-3904-2","article-title":"Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer","volume":"21","author":"Noori","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pathol.2017.03.002_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/gcc.20330","article-title":"A\u00a0genome wide linkage search for breast cancer susceptibility genes","volume":"45","author":"Smith","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/bjs.5344","article-title":"Contralateral recurrence and prognostic factors in familial non-BRCA1\/2-associated breast cancer","volume":"93","author":"Tilanus-Linthorst","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.pathol.2017.03.002_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-005-9054-2","article-title":"Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1\/2 patients","volume":"95","author":"Tilanus-Linthorst","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pathol.2017.03.002_bib42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-009-0653-1","article-title":"Subtypes of familial breast tumours revealed by expression and copy number profiling","volume":"123","author":"Waddell","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pathol.2017.03.002_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13053-015-0036-z","article-title":"Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden","volume":"13","author":"Wendt","year":"2015","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.pathol.2017.03.002_bib44","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/bcr3369","article-title":"The risk of contralateral breast cancer in patients from BRCA1\/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study","volume":"14","author":"Rhiem","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.pathol.2017.03.002_bib45","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.ejca.2005.02.037","article-title":"Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy","volume":"41","author":"Kirova","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2017.03.002_bib47","first-page":"782","article-title":"The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2","volume":"6","author":"Lakhani","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2017.03.002_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib49","first-page":"560","article-title":"Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene","volume":"8","author":"Zukerberg","year":"1995","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2017.03.002_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/bjc.1996.128","article-title":"A\u00a0clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer","volume":"73","author":"Michalides","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-008-0075-5","article-title":"BRCA1 promoter methylation is associated with increased mortality among women with breast cancer","volume":"115","author":"Xu","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pathol.2017.03.002_bib52","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jnci\/dji281","article-title":"Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families","volume":"97","author":"Kauff","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2017.03.002_bib53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jmedgenet-2013-101607","article-title":"Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2","volume":"50","author":"Ingham","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.pathol.2017.03.002_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1897-4287-5-1-17","article-title":"A\u00a0hypothesis-generating search for new genetic breast cancer syndromes\u2014a national study in 803 Swedish families","volume":"5","author":"von Wachenfeldt","year":"2007","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.pathol.2017.03.002_bib55","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.1626","article-title":"German Consortium for Hereditary Breast and Ovarian Cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population","volume":"97","author":"Meindl","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2017.03.002_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11048","article-title":"Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers","volume":"97","author":"Adem","year":"2003","journal-title":"Cancer"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302517300806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302517300806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:20:02Z","timestamp":1535872802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302517300806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0031302517300806"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2017.03.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-BRCA familial breast cancer: review of reported pathology and molecular findings","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Royal College of Pathologists of Australasia. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}